Billions and Billions Part II

I am not channeling Carl Sagan; I am keeping a running total of the fines imposed on the Life Sciences industry for Good Promotional Practices violations, and specifically for off-label, or unapproved use-case, marketing. (See my earlier post for the 2010 wrap-up.) 4Q2011 is not shaping up to be such a great quarter for LS [...]

Continue Reading…

Are Digital and Multi-Channel Marketing now one and the Same?

This post is a summarized version of my article for pharmaphorum, which you can read here. Digital Pharma West was all about digital media’s role in pharma. I was on one panel that specifically dealt with the question: “Is digital and multi-channel marketing now one and the same?” The definitive conclusion of the panelists: no. Digital [...]

Continue Reading…

The Dangers of Frugalnomics

Merriam-Webster defines “frugalnomics” as “the economics of being frugal”. Due to the economic turbulence of the last decade, this trait has been adopted by businesses and consumers en-masse– often resulting in procrastination. Companies and people delay decisions that save short-term cash, but may cause greater harm in the long run. A simple example of this is delaying [...]

Continue Reading…

Can’t You Hear the Whistleblowing?

A recent study featured in PLoS Medicine  examined 41 unsealed whistleblower complaints to find the most common strategies and practices reported in federal fraud cases in the last two decades. Their results show that illegal off-label promotions often span company-wide in both large, prominent pharmaceutical companies and smaller, more specialized companies. Most disturbingly, in 90% of [...]

Continue Reading…

Gun-sights, Targets and Uncertainty

Pharma and life sciences execs must be feeling a bit like Hal in this epic cartoon from The Far Side: The FDA and DOJ seem to have similar targets on senior executives in the life sciences industry for potential prosecution. Why? Applying strict legislative consequences for breaking federal regulations saves the federal government money, motivates life [...]

Continue Reading…

TWITTER

Prolifiq on Twitter

BLOGS

 
by: Jeff Gaus - 05/17/2012
by: Jeff Gaus - 05/10/2012
by: Jeff Gaus - 05/08/2012

4145 SW Watson Ave., Suite 450 Beaverton, OR 97005

Inquiries: +1.800.840.7183
Main: +1.503.684.1415
Fax: +1.503.968.3095

E-MAIL US
SUPPORT

Follow Us
Twitter Facebook LinkedIn
Copyright © 2012 Prolifiq Software Inc. All rights reserved. Prolifiq and the Prolifiq logo mark are registered trademarks with the U.S. Patent Office. Other trademarks held by their respective owners. Privacy Policy